Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Phase 1a/b Study of HC-7366 in Subjects With Advanced Solid Tumors

NCT05121948 is registered in ClinicalTrials.gov with HiberCell, Inc. as lead sponsor.

NCT NCT05121948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05121948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Phase 1a/b Study of HC-7366 in Subjects With Advanced Solid Tumors
Lead sponsor
HiberCell, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
February 23, 2022
Completion date
March 1, 2024
Enrollment
35 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, colo-rectal cancer, non small cell lung cancer, other solid tumors, squamous cell carcinoma of head and neck, transitional cell carcinoma of the bladder